SynbiCITE
Overview
SynbiCITE is the United Kingdom's National Industrial Translation Centre for Engineering Biology, acting as an accelerator and incubator to bridge the gap between academic research and commercial application in the synthetic biology sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Prokarium | Feb 2023 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SynbiCITE based?
SynbiCITE is headquartered in London, United Kingdom.
When was SynbiCITE founded?
SynbiCITE was founded in 2013.
How many portfolio companies does SynbiCITE have?
SynbiCITE has 2 portfolio companies in Caplight's dataset.
What are some companies in SynbiCITE's portfolio?
Portfolio companies visible on Caplight include Prokarium.
What was SynbiCITE's most recent investment shown here?
SynbiCITE's most recent investment in this portfolio sample was in Prokarium in 2023.
What sectors does SynbiCITE focus on?
SynbiCITE focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does SynbiCITE focus on?
Stage focus information for SynbiCITE is not publicly available.
What is SynbiCITE's AUM?
SynbiCITE's assets under management are estimated between $0.0 and $50.0M.